BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 25054061)

  • 1. Diagnosis and surgical management of breast cancer metastatic to the spine.
    Ju DG; Yurter A; Gokaslan ZL; Sciubba DM
    World J Clin Oncol; 2014 Aug; 5(3):263-71. PubMed ID: 25114843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.
    Fujibuchi T; Imai H; Kidani T; Miura H
    SAGE Open Med; 2022; 10():20503121221097582. PubMed ID: 35646367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
    Lawrenz JM; Gordon J; George J; Haben C; Rubin BP; Ilaslan H; Mesko NW; Nystrom LM
    Clin Orthop Relat Res; 2020 Nov; 478(11):2451-2457. PubMed ID: 33112582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
    Greenberg DD
    Clin Orthop Relat Res; 2020 Nov; 478(11):2458-2460. PubMed ID: 32667762
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
    Park SB; Park JM; Moon SH; Cho YS; Sun JM; Kim BT; Lee KH
    PLoS One; 2018; 13(5):e0196808. PubMed ID: 29746513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.
    Tominaga H; Setoguchi T; Shimada H; Nagano S; Sasaki H; Ishidou Y; Sato M; Mizuno K; Inoue H; Komiya S
    Mol Clin Oncol; 2017 Nov; 7(5):897-902. PubMed ID: 29181185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Diagnostic Performance of Three-Dimensional Positron Emission Mammography versus Whole Body Positron Emission Tomography in Breast Cancer.
    Dai D; Song X; Wang M; Li L; Ma W; Xu W; Ma Y; Liu J; Zhang J; Liu P; Gu X; Su Y
    Contrast Media Mol Imaging; 2017; 2017():5438395. PubMed ID: 29097927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic scoring systems for bone metastases using single-center data.
    Shimada H; Setoguchi T; Nakamura S; Yokouchi M; Ishidou Y; Tominaga H; Kawamura I; Nagano S; Komiya S
    Mol Clin Oncol; 2015 Nov; 3(6):1361-1370. PubMed ID: 26807248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.
    Takagi T; Katagiri H; Kim Y; Suehara Y; Kubota D; Akaike K; Ishii M; Mukaihara K; Okubo T; Murata H; Takahashi M; Kaneko K; Saito T
    PLoS One; 2015; 10(6):e0129428. PubMed ID: 26115010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic bone tumors: Analysis of factors affecting prognosis and efficacy of CT and
    Shimada H; Setoguchi T; Yokouchi M; Sasaki H; Ishidou Y; Kawamura I; Abematsu M; Nagano S; Komiya S
    Mol Clin Oncol; 2014 Sep; 2(5):875-881. PubMed ID: 25054061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.
    Capitanio S; Bongioanni F; Piccardo A; Campus C; Gonella R; Tixi L; Naseri M; Pennone M; Altrinetti V; Buschiazzo A; Bossert I; Fiz F; Bruno A; DeCensi A; Sambuceti G; Morbelli S
    World J Radiol; 2016 Feb; 8(2):200-9. PubMed ID: 26981229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.